A Non-Interventional Study to Evaluate the Effectiveness of Delayed-Release Prednisone (RAYOS) on Clinical Assessments and Serologic Disease Activity in Patients With Active Rheumatoid Arthritis in the Clinical Practice Setting
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Prednisone (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms SUNRAY
- Sponsors Horizon Pharma
- 31 Aug 2018 Biomarkers information updated
- 18 Mar 2016 Status changed from recruiting to completed as reported by Clinicaltrials.gov.
- 25 Jan 2016 Planned End Date changed from 1 Oct 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.